Understanding Waldenström Macroglobulinemia Treating Blood Cancers

Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA

























Recorded on December 6, 2022







Shayna Sarosiek, MD

Assistant Professor

Harvard Medical School

Dana Farber Cancer Institute

Boston, MA





Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic factors? Dr. Shayna Sarosiek, from the Dana-Farber Cancer Institute, joins us to provide a deep dive into WM, including testing, monitoring, treatment updates, clinical trials, and so much more. Tune in today!











This activity is developed through a collaboration with the International Waldenström’s Macroglobulinemia Foundation.